von Willebrand disease: from the bedside to therapy.
Von Willebrand's disease was recognized by a careful observant clinician. Research advances in blood banking technology and molecular biology, in addition to astute clinical observation, have led to unraveling the factor VIII molecule, classification of a heterogenous disease, and rational therapy.
Aledort
L M
LM
Mount Sinai School of Medicine, New York, NY, USA.
D003894:Deamino Arginine Vasopressin / Q000627:therapeutic use; D005169:Factor VIII / Q000378:metabolism; D006801:Humans; D013329:Structure-Activity Relationship; D014842:von Willebrand Diseases / Q000503:physiopathology / Q000628:therapy*; D014841:von Willebrand Factor / Q000737:chemistry* / Q000502:physiology
D014841:von Willebrand Factor; D005169:Factor VIII; D003894:Deamino Arginine Vasopressin